Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil

• Published in: Revista da Sociedade Brasileira de Medicina Tropical 2013-05, Vol.46 (3), p.335-339
• Main Authors: Almeida, Adriana Araújo de, Mesquita, Cristiane Suemi Shinobu, Svidzinski, Terezinha Inez Estivalet, Oliveira, Kelly Mari Pires de
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Amphotericin B; Amphotericin B - pharmacology; Antifungal Agents - pharmacology; Antimicrobial agents; Brazil; Candida; Candida - classification; Candida - drug effects; Candida - isolation & purification; Candidemia; Candidiasis - microbiology; Candiduria; Child; Child, Preschool; Cross Infection - microbiology; Epidemiology; Female; Fluconazole; Fluconazole - pharmacology; Fungal infections; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Nosocomial infections; TROPICAL MEDICINE; Yeast; Young Adult
• ISSN: 0037-8682; 1678-9849; 1678-9849; 0037-8682
• DOI: 10.1590/0037-8682-0074-2012

Hospital infections caused by Candida spp. are a leading cause of morbidity and mortality in hospitalized patients, particularly those that are critically ill or immunocompromised. In this study, the distribution of Candida species in isolates from the University Hospital of the Federal University at Grande Dourados and their in vitro susceptibility to antifungal drugs were analyzed. Yeasts were phenotypically identified using classical methodologies. Antifungal susceptibility tests to amphotericin B and fluconazole were performed using the broth microdilution technique. A total of 50 Candida isolates were obtained from hospitalized patients during the study period. We analyzed yeast isolates from urine (n=31; 62%), blood (n=12; 24%), and tracheal secretions (n=7; 14%). The following Candida species were identified: C. tropicalis (n=21; 42%), C. albicans (n=18; 36%), C. glabrata (n=10; 20%), and C. krusei (n=1; 2%). Antifungal susceptibility tests demonstrated that C. albicans was susceptible to both antifungal agents. However, 31.2% of the non-C. albicans Candida isolates displayed dose-dependent susceptibility to fluconazole, and 3.1% were resistant to amphotericin B. In contrast to previous reports, our results indicated that C. tropicalis was the most commonly isolated yeast species among the hospital patients. The predominance of non-C. albicans Candida infections confirms the importance of species-level identification for implementing appropriate antifungal therapies.